litlas
Log inCreate account

Jean‐Marc Herbert

Active 1990–2013

Also published as
Jean Marc Herbert · Jean-Marc Herbert
75
Papers
21,862
Citations
75
h-index
75
i10-index

Citations

Citations per year for Jean‐Marc Herbert1951: 1 citations1989: 1 citations1991: 3 citations1992: 4 citations1993: 12 citations1994: 17 citations1995: 36 citations1996: 52 citations1997: 45 citations1998: 96 citations1999: 125 citations2000: 190 citations2001: 241 citations2002: 298 citations2003: 411 citations2004: 422 citations2005: 438 citations2006: 396 citations2007: 331 citations2008: 341 citations2009: 355 citations2010: 282 citations2011: 260 citations2012: 215 citations2013: 210 citations2014: 185 citations2015: 137 citations2016: 117 citations2017: 98 citations2018: 105 citations2019: 297 citations2020: 318 citations2021: 311 citations2022: 177 citations2023: 144 citations2024: 188 citations2025: 75 citations2026: 2 citations1952–1988: no citations, so these years are not shown1990: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,658 citing papers, 31.7% of this breakdownUnited Kingdom: 604 citing papers, 7.2% of this breakdownGermany: 565 citing papers, 6.7% of this breakdownChina: 561 citing papers, 6.7% of this breakdownFrance: 448 citing papers, 5.3% of this breakdownItaly: 394 citing papers, 4.7% of this breakdownJapan: 365 citing papers, 4.4% of this breakdownCanada: 297 citing papers, 3.5% of this breakdownBelgium: 285 citing papers, 3.4% of this breakdownNetherlands: 227 citing papers, 2.7% of this breakdownSwitzerland: 193 citing papers, 2.3% of this breakdownSweden: 178 citing papers, 2.1% of this breakdown
0%31.7%Other 19.3%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology45.4%
  • Medicine39.1%
  • Immunology and Microbiology5.6%
  • Neuroscience4.4%
  • Pharmacology, Toxicology and Pharmaceutics1.6%
  • Chemistry0.8%
  • Other3.1%

Topics

  • Angiogenesis and VEGF in Cancer7.1%
  • Cancer, Hypoxia, and Metabolism6%
  • Antiplatelet Therapy and Cardiovascular Diseases2.3%
  • Blood Coagulation and Thrombosis Mechanisms2.1%
  • Platelet Disorders and Treatments1.9%
  • Cell Adhesion Molecules Research1.4%
  • Other79.2%

Coauthors

All papers

Open in search
  1. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

    Authors: Peter Carmeliet, Yuval Dor, Jean-Marc Herbert, Dai Fukumura, Koen Brusselmans, Mieke Dewerchin, Michal Neeman, Françoise Bono, Rinat Abramovitch, Patrick H. Maxwell, Cameron J. Koch, Peter J. Ratcliffe, Lieve Moons, Rakesh K. Jain, Désiré Collen, Eli Keshet - Nature 1998 cited by 2,505

  2. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions

    Authors: Peter Carmeliet, Lieve Moons, Aernout Luttun, Valeria Vincenti, Veerle Compernolle, Maria De Mol, Yan Wu, Françoise Bono, Laetitia Devy, Heike Beck, Dimitri Scholz, Till Acker, Tina Di Palma, Mieke Dewerchin, Agnès Noël, Ingeborg Stalmans, Adriano Barra, S. Blacher, Thierry VandenDriessche, Annica Pontén, Ulf Eriksson, Karl H. Plate, Jean‐Michel Foidart, Wolfgang Schäper, D. Stephen Charnock‐Jones, Daniel J. Hicklin, Jean‐Marc Herbert, D Collen, M. Graziella Persico - Nature Medicine 2001 cited by 1,667

  3. Targeted Deficiency or Cytosolic Truncation of the VE-cadherin Gene in Mice Impairs VEGF-Mediated Endothelial Survival and Angiogenesis

    Authors: Peter Carmeliet, Maria Grazia Lampugnani, Lieve Moons, F Breviario, Veerle Compernolle, Françoise Bono, Giovanna Balconi, Raffaella Spagnuolo, Bert Oosthuyse, Mieke Dewerchin, Adriana Zanetti, Anne Angellilo, Virginie Mattot, Dieter Nuyens, Esther Lutgens, Frédéric Clotman, M. Ruiter, Adriana Gittenberger-de Groot, Rob E. Poelmann, Florea Lupu, Jean‐Marc Herbert, Désiré Collen, Elisabetta Dejana - Cell 1999 cited by 1,287

  4. VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis

    Authors: Fan Zhang, Zhongshu Tang, Xu Hou, Johan Lennartsson, Yang Li, Alexander Koch, Pierre Scotney, Chunsik Lee, Pachiappan Arjunan, Lijin Dong, Anil Kumar, Tuomas T. Rissanen, Bin Wang, Nobuo Nagai, Pierre Fons, Robert N. Fariss, Yongqing Zhang, Eric F. Wawrousek, Ginger Tansey, James Raber, Guo‐Hua Fong, Hao Ding, David A. Greenberg, Kevin G. Becker, Jean‐Marc Herbert, Andrew D. Nash, Seppo Ylä‐Herttuala, Yihai Cao, Ryan J. Watts, Xuri Li - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 cited by 308

  5. Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy

    Authors: Anne Angelillo‐Scherrer, Laurent Burnier, Nathalie Flores, Pierre Savi, Maria DeMol, Paul Schaeffer, Jean-Marc Herbert, Greg Lemke, Stephen P. Goff, Glenn K. Matsushima, H. Shelton Earp, Christian Vesin, Marc Hoylaerts, Stéphane Plaisance, Désiré Collen, Edward M. Conway, Bernhard Wehrle‐Haller, Peter Carmeliet - Journal of Clinical Investigation 2005 cited by 259

  6. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration

    Authors: Bert Oosthuyse, Lieve Moons, Erik Storkebaum, Heike Beck, Dieter Nuyens, Koen Brusselmans, Jo Van Dorpe, Peter W. Hellings, M. Gorselink, Stéphane Heymans, Gregor Theilmeier, Mieke Dewerchin, Vincent Laudenbach, P. Vermylen, Harold Raat, Till Acker, V. Vleminckx, Ludo Van Den Bosch, Neil R. Cashman, Hajime Fujisawa, Maarten R. Drost, Raf Sciot, Frans Bruyninckx, Daniel J. Hicklin, Can İnce, Pierre Gressèns, Florea Lupu, Karl H. Plate, Wim Robberecht, Jean‐Marc Herbert, Désiré Collen, Peter Carmeliet - Nature Genetics 2001 cited by 1,010

  7. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

    Authors: Monica Autiero, Johannes Waltenberger, Didier Communi, Andrea Kranz, Lieve Moons, Diether Lambrechts, Jens Krøll, Stéphane Plaisance, Maria De Mol, Françoise Bono, Stefanie Kliche, Guido Fellbrich, Kurt Ballmer‐Hofer, Domenico Maglione, Ulrike Mayr-Beyrle, Mieke Dewerchin, Saskia Dombrowski, Danica Stanimirovic, Paul Van Hummelen, Christoph Dehio, Daniel J. Hicklin, Graziella Persico, Jean‐Marc Herbert, David Communi, Masabumi Shibuya, D Collen, Edward M. Conway, Peter Carmeliet - Nature Medicine 2003 cited by 766

  8. Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration

    Authors: Benoı̂t Favier, Antoine Alam, Pauline Barron, Jacques Bonnin, Patricia Laboudie, Pierre Fons, Marie Mandron, Jean-Pascal Hérault, Gera Neufeld, Pierre Savi, Jean‐Marc Herbert, Françoise Bono - Blood 2006 cited by 294

  9. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1

    Authors: Aernout Luttun, Marc Tjwa, Lieve Moons, Yan Wu, Anne Angelillo‐Scherrer, Fang Liao, Janice A. Nagy, Andrea T. Hooper, Josef Priller, Bert De Klerck, Veerle Compernolle, Evis Daci, Peter Böhlen, Mieke Dewerchin, Jean-Marc Herbert, Roy A. Fava, Patrick Matthys, Geert Carmeliet, D Collen, Harold F. Dvorak, Daniel J. Hicklin, Peter Carmeliet - Nature Medicine 2002 cited by 1,062

  10. Peroxisome Proliferator-activated Receptor α Activators Improve Insulin Sensitivity and Reduce Adiposity

    Authors: Michèle Guerre-Millo, Philippe Gervois, Eric Raspé, Lise Madsen, Philippe Poulain, Bruno Derudas, Jean-Marc Herbert, Deborah A. Winegar, Timothy M. Willson, Jean‐Charles Fruchart, Rolf K. Berge, Bart Staels - Journal of Biological Chemistry 2000 cited by 603

  11. Inhibition of Tumor Angiogenesis and Growth by a Small-Molecule Multi-FGF Receptor Blocker with Allosteric Properties

    Authors: Françoise Bono, Frederik De Smet, Corentin Herbert, Katrien De Bock, Μαρία Γεωργιάδου, Pierre Fons, Marc Tjwa, Chantal Alcouffe, Annelii Ny, Marc Bianciotto, Bart Jonckx, Masahiro Murakami, Anthony A. Lanahan, Christof Michielsen, David Sibrac, Frédérique Dol-Gleizes, Massimiliano Mazzone, Serena Zacchigna, Jean-Pascal Hérault, Christian Fischer, Patrice Rigon, Carmen Ruiz de Almodóvar, Filip Claes, Isabelle Blanc, Koen Poesen, Jie Zhang, Inmaculada Segura, G. Guéguen, Marie-Françoise Bordes, Diether Lambrechts, Roselyne Broussy, Marlies Van de Wouwer, Corinne Michaux, Toru Shimada, Isabelle Jean, Silvia Blacher, Agnès Noël, Patrick Motté, Eran Rom, Jean‐Marie Rakic, Susumu Katsuma, Paul Schaeffer, Avner Yayon, Ann Van Schepdael, Harald Schwalbe, Francesco Luigi Gervasio, Geert Carmeliet, Jef Rozensky, Mieke Dewerchin, Michael Simons, Arthur Christopoulos, Jean‐Marc Herbert, Peter Carmeliet - Cancer Cell 2013 cited by 146

  12. SSR182289A, a selective and potent orally active thrombin inhibitor

    Authors: J.M. Altenburger, Gilbert Lassalle, Mostapha Matrougui, Daniel Galtier, Jean-Claude Jetha, Zsolt Böcskei, Christopher N. Berry, Catherine Lunven, J Lorrain, Jean-Pascal Hérault, Paul Schaeffer, Stephen E. O'Connor, Jean‐Marc Herbert - Bioorganic & Medicinal Chemistry 2004 cited by 132

  13. Chelerythrine is a potent and specific inhibitor of protein kinase C

    Authors: Jean‐Marc Herbert, Jean‐Michel Augereau, J. Gleye, J.P. Maffrand - Biochemical and Biophysical Research Communications 1990 cited by 1,207

  14. Identification and Biological Activity of the Active Metabolite of Clopidogrel

    Authors: Pierre Savi, Jean‐Marie Pereillo, Marie-Françoise Uzabiaga, Jean Combalbert, C. Picard, Jean‐Pierre Maffrand, Marc Pascal, Jean‐Marc Herbert - Thrombosis and Haemostasis 2000 cited by 748

  15. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis

    Authors: Anne Angelillo‐Scherrer, Pablo Garcı́a de Frutos, Cristina Aparicio, Els Melis, Pierre Savi, Florea Lupu, Jef Arnout, Mieke Dewerchin, Marc Hoylaerts, Jean‐Marc Herbert, Désiré Collen, Björn Dahlbäck, Peter Carmeliet - Nature Medicine 2001 cited by 436

  16. The Lectin-like Domain of Thrombomodulin Confers Protection from Neutrophil-mediated Tissue Damage by Suppressing Adhesion Molecule Expression via Nuclear Factor κB and Mitogen-activated Protein Kinase Pathways

    Authors: Edward M. Conway, Marlies Van de Wouwer, Saskia Pollefeyt, Kerstin Jurk, Hugo Van Aken, Astrid De Vriese, Jeffrey I. Weitz, Hartmut Weiler, Peter W. Hellings, Paul Schaeffer, Jean‐Marc Herbert, D Collen, Gregor Theilmeier - The Journal of Experimental Medicine 2002 cited by 349

  17. Synthesis of thrombin-inhibiting heparin mimetics without side effects

    Authors: Maurice Petitou, Jean-Pascal Hérault, A. Bernat, Pierre‐Alexandre Driguez, Philippe Duchaussoy, Jean‐Claude Lormeau, Jean‐Marc Herbert - Nature 1999 cited by 323

  18. Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes

    Authors: Marc Tjwa, Lola Bellido‐Martín, Yuan Lin, Esther Lutgens, Stéphane Plaisance, Françoise Bono, Nathalie Delesque-Touchard, Caroline Hervé, Rute Moura, An Billiau, Cristina Aparicio, Marcel Levi, Mat J.A.P. Daemen, Mieke Dewerchin, Florea Lupu, Jef Arnout, Jean‐Marc Herbert, Mark Waer, Pablo Garcı́a de Frutos, Björn Dahlbäck, Peter Carmeliet, Marc Hoylaerts, Lieve Moons - Blood 2007 cited by 160

  19. Conversion of human fibroblasts to angioblast-like progenitor cells

    Authors: Leo Kurian, Ignacio Sancho-Martinez, Emmanuel Nivet, Aitor Aguirre, Krystal Moon, Caroline Pendaries, Cécile Volle‐Challier, Françoise Bono, Jean‐Marc Herbert, Julián Pulecio, Yun Xia, Mo Li, Núria Montserrat, Sergio Ruiz, Ilir Dubova, Concepción Rodríguez, Ahmet M. Denli, Francesca S. Boscolo, Rathi D. Thiagarajan, Fred H. Gage, Jeanne F. Loring, Louise C. Laurent, Juan Carlos Izpisúa Belmonte - Nature Methods 2012 cited by 150

  20. Structure and Stereochemistry of the Active Metabolite of Clopidogrel

    Authors: Jean‐Marie Pereillo, Mohamed Maftouh, Alain Andrieu, Marie-Françoise Uzabiaga, Olivier Fedeli, Pierre Savi, Marc Pascal, Jean‐Marc Herbert, Jean‐Pierre Maffrand, C. Picard - Drug Metabolism and Disposition 2002 cited by 458

  21. The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts

    Authors: Pierre Savi, Jean‐Luc Zachayus, Nathalie Delesque-Touchard, Catherine Labouret, Caroline Hervé, Marie-Françoise Uzabiaga, Jean‐Marie Pereillo, Jean‐Michel Culouscou, Françoise Bono, Pascual Ferrara, Jean‐Marc Herbert - National Academy of Sciences, Proceedings of the National Academy of Sciences 2006 cited by 318

  22. Genetic evidence for a tumor suppressor role of HIF-2α

    Authors: Till Acker, Antonio Díez‐Juan, Julián Aragonés, Marc Tjwa, Koen Brusselmans, Lieve Moons, Dai Fukumura, Paz Moreno-Murciano, Jean‐Marc Herbert, Angelika M. Burger, Johanna Riedel, Gerd Elvert, Ingo Flamme, Patrick H. Maxwell, Désiré Collen, Mieke Dewerchin, Rakesh K. Jain, Karl H. Plate, Peter Carmeliet - Cancer Cell 2005 cited by 183

  23. Molecular Mechanism of SSR128129E, an Extracellularly Acting, Small-Molecule, Allosteric Inhibitor of FGF Receptor Signaling

    Authors: Corentin Herbert, Ulrich Schieborr, Krishna Saxena, Jarek Juraszek, Frederik De Smet, Chantal Alcouffe, Marc Bianciotto, Giorgio Saladino, David Sibrac, D. Kudlinzki, Sridhar Sreeramulu, Alan Brown, Patrice Rigon, Jean-Pascal Hérault, Gilbert Lassalle, Tom L. Blundell, Frédéric Rousseau, Ann Gils, Joost Schymkowitz, Péter Tompa, Jean‐Marc Herbert, Peter Carmeliet, Francesco Luigi Gervasio, Harald Schwalbe, Françoise Bono - Cancer Cell 2013 cited by 127

  24. Verbascoside Isolated from Lantana camara, an Inhibitor of Protein Kinase C

    Authors: Jean Marc Herbert, J.P. Maffrand, K. Taoubi, Jean‐Michel Augereau, I. Fourasté, J. Gleye - Journal of Natural Products 1991 cited by 110